|
House Bill
|
1
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
348
|
An Act relative to the licensure of behavior analysts
|
Neutral
|
$0.00
|
NA
|
|
House Bill
|
1082
|
An Act to enact the pharmacy benefit manager compensation reform
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
1091
|
An Act relative to pharmacists as healthcare providers
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
1092
|
An Act to ensure affordable prescription medications through accountability standards
|
Support
|
$0.00
|
NA
|
|
House Bill
|
1091
|
An Act relative to pharmacists as healthcare providers
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
1101
|
An Act relative to consumer deductibles
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
1123
|
An Act relative to notices by insurance companies
|
Support
|
$0.00
|
NA
|
|
House Bill
|
1125
|
An Act relative to non-medical switching
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1133
|
An Act relative to patient financial protection
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1144
|
An Act to protect health care consumers from surprise billing
|
Support
|
$0.00
|
na
|
|
House Bill
|
1154
|
An Act relative to insurance coverage of mobile integrated health
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1155
|
An Act empowering health care consumers
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1157
|
An Act to ensure access to prescription medication and community pharmacies
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1222
|
An Act relative to prescription medication re-authorization
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1227
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1234
|
An Act relative to pharmacy benefit managers
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1250
|
An Act relative to greater fairness in insurance
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1274
|
An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1298
|
An Act to increase enrollment in affordable health plan networks
|
Support
|
$0.00
|
na
|
|
House Bill
|
1305
|
An Act to help patients and reduce health care costs by ensuring patient adherence to medications
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1309
|
An Act assuring prompt access to health care
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1321
|
An Act relative to transparency of consumer health insurance rights
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1324
|
An Act relative to prescription drug pricing
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1325
|
An Act to ensure access to generic medication
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1326
|
An Act to ensure access to prescription medications
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1330
|
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth
|
Oppose
|
$0.00
|
na
|
|
House Bill
|
1350
|
An Act to address medical debt through hospital financial assistance reform
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
1354
|
An Act to address the financial sustainability of the Health Safety Net
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
1355
|
An Act strengthening oversight of health care facility spending
|
Support
|
$0.00
|
NA
|
|
House Bill
|
1356
|
An Act relative to transparency of hospital and health system finances
|
Support
|
$0.00
|
NA
|
|
House Bill
|
1357
|
An Act relative to insurer responsibility to the operating budgets of health care oversight entities
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
1361
|
An Act to address health care costs through the cost benchmark and rate review processes
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
1364
|
An Act relative to promoting healthcare access and affordability for patients
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
1370
|
An Act relative to Massachusetts primary care for you
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
1384
|
An Act updating the health care cost growth benchmark and associated market oversight activities
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
1396
|
An Act strengthening mental health centers
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
2192
|
An Act to promote high value and evidence-based behavioral health care
|
Support
|
$0.00
|
NA
|
|
House Bill
|
2384
|
An Act relative to provider choice
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
2535
|
An Act establishing a Naloxone Purchase Trust fund
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
2537
|
An Act relative to primary care access
|
Oppose
|
$0.00
|
NA
|
|
House Bill
|
4043
|
An Act relative to copay assistance for medications
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
NA
|
|
Senate Bill
|
687
|
An Act ensuring access to fair and reasonable pharmacy networks
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
693
|
An Act relative to non-medical switching
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
694
|
An Act empowering health care consumers
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
734
|
An Act ensuring access to specialty medications
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
775
|
An Act to increase enrollment in affordable health plan networks
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
777
|
An Act relative to specialty medications and patient safety
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
781
|
An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
800
|
An Act relative to pharmacists as healthcare providers
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
809
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
827
|
An Act to ensure access to prescription medications
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
830
|
An Act to preserve community pharmacies
|
Support
|
$0.00
|
NA
|
|
Senate Bill
|
830
|
An Act to preserve community pharmacies
|
Support
|
$0.00
|
NA
|
|
Senate Bill
|
831
|
An Act to ensure access to prescription medication and community pharmacies
|
Support
|
$0.00
|
NA
|
|
Senate Bill
|
863
|
An Act relative to non-opioid options for chronic pain
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
867
|
An Act relative to primary care for you
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
868
|
An Act enhancing health care market oversight and pharmaceutical access
|
Support
|
$0.00
|
NA
|
|
Senate Bill
|
874
|
An Act strengthening mental health centers
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
875
|
An Act to promote transparency in prescription drug prices
|
Support
|
$0.00
|
NA
|
|
Senate Bill
|
891
|
An Act relative to the primary care workforce development and loan repayment grant program at community health centers
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
894
|
An Act relative to coverage for chronic illness
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
895
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Support
|
$0.00
|
NA
|
|
Senate Bill
|
902
|
An Act lowering health care prices for patients
|
Support
|
$0.00
|
NA
|
|
Senate Bill
|
1514
|
An Act relative to provider choice
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
1514
|
An Act relative to provider choice
|
Oppose
|
$0.00
|
NA
|
|
Senate Bill
|
1551
|
An Act establishing a naloxone purchase trust fund
|
Support
|
$0.00
|
NA
|
|
Senate Bill
|
1635
|
An Act authorizing pharmacists to provide opioid use disorder treatment
|
Support
|
$0.00
|
NA
|
|
Senate Bill
|
2540
|
An Act making appropriations for the fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects
|
Support
|
$0.00
|
NA
|
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussion with Division of Insurance on Mental Health Parity
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussion with Division of Insurance on Pharmacy Benefit Manager Licensure
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussion with Division of Insurance on Step Therapy Annual Reporting
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussion with Division of Insurance on Implementation of Coverage of Naloxone as a Medical Benefit
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussion with Division of Insurance on Implementation of Coverage of Naloxone as a Medical Benefit
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussion with Division of Insurance on Implementation of Coverage of Naloxone as a Medical Benefit
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussion with Division of Insurance on Implementation of Coverage of Naloxone as a Medical Benefit
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussion with Division of Insurance on Pain Management & Carrier Alternatives Spreadsheet
|
Support
|
$0.00
|
NA
|
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussions with the Division of Insurance on Filing Guidance Notice 2025-E – Certain drugs for chronic conditions.
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Discussions with the Massachusetts Health Policy Commission on the Health Care Cost Growth Benchmark
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Discussions with Massachusetts Health Policy Commission on Primary Care Access, Delivery, and Payment Task Force
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Discussions with Massachusetts Health Policy Commission on Primary Care Access, Delivery, and Payment Task Force
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
MassHealth
|
Discussions with MassHealth regarding Model B Information Sharing
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
MassHealth
|
Discussions with MassHealth regarding Applied Behavioral Analysis funding
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
MassHealth
|
Discussions with MassHealth regarding Applied Behavioral Analysis funding
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
MassHealth
|
Discussions with MassHealth regarding GLP-1 funding
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
MassHealth
|
Discussions with MassHealth regarding Health Safety Net
|
Neutral
|
$0.00
|
NA
|
|
Executive
|
MassHealth
|
Discussions with MassHealth on the managed care pricing workgroup
|
Neutral
|
$0.00
|
na
|
|
Executive
|
MassHealth
|
Discussions with MassHealth regarding the payor assessment
|
Neutral
|
$0.00
|
na
|
|
Executive
|
Department of Mental Health (DMH)
|
Discussions with the Department of Mental Health regarding the Behavioral Health Treatment and Referral Platfom
|
Neutral
|
$0.00
|
na
|
| | | |
Total amount
|
$0.00
| |